Artivion (NYSE:AORT) Stock Price Up 5.9%

Artivion, Inc. (NYSE:AORT)’s stock price traded up 5.9% during trading on Friday . The company traded as high as $27.35 and last traded at $27.28. 123,308 shares changed hands during mid-day trading, a decline of 45% from the average session volume of 225,462 shares. The stock had previously closed at $25.76.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Stifel Nicolaus lifted their price objective on shares of Artivion from $28.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, September 13th. Needham & Company LLC reissued a “buy” rating and issued a $30.00 price objective on shares of Artivion in a research note on Friday. Lake Street Capital lifted their price target on shares of Artivion from $28.00 to $30.00 and gave the stock a “buy” rating in a research note on Tuesday, July 2nd. Finally, Oppenheimer lifted their price target on shares of Artivion from $25.00 to $30.00 and gave the stock an “outperform” rating in a research note on Friday, August 9th.

Artivion Stock Performance

The company has a current ratio of 5.63, a quick ratio of 4.04 and a debt-to-equity ratio of 1.07. The business’s 50 day moving average is $25.85 and its 200 day moving average is $23.81. The stock has a market capitalization of $1.14 billion, a PE ratio of -107.46 and a beta of 1.74.

Artivion (NYSE:AORT) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. Artivion had a negative net margin of 2.22% and a positive return on equity of 3.81%. The company had revenue of $98.02 million during the quarter, compared to analyst estimates of $97.70 million. On average, equities research analysts predict that Artivion, Inc. will post 0.2 earnings per share for the current fiscal year.

Insider Activity at Artivion

In related news, SVP Jean F. Holloway sold 2,383 shares of Artivion stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $25.76, for a total transaction of $61,386.08. Following the completion of the sale, the senior vice president now owns 165,099 shares in the company, valued at approximately $4,252,950.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, VP Matthew A. Getz sold 9,420 shares of the business’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $25.31, for a total value of $238,420.20. Following the completion of the sale, the vice president now owns 34,116 shares in the company, valued at approximately $863,475.96. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Jean F. Holloway sold 2,383 shares of the business’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $25.76, for a total transaction of $61,386.08. Following the completion of the sale, the senior vice president now owns 165,099 shares of the company’s stock, valued at approximately $4,252,950.24. The disclosure for this sale can be found here. Insiders sold 24,679 shares of company stock worth $626,518 in the last 90 days. 8.10% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the company. Perceptive Advisors LLC raised its stake in shares of Artivion by 4.7% during the 2nd quarter. Perceptive Advisors LLC now owns 2,793,703 shares of the company’s stock worth $71,658,000 after acquiring an additional 124,725 shares in the last quarter. Vanguard Group Inc. grew its position in Artivion by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 2,664,855 shares of the company’s stock worth $56,388,000 after purchasing an additional 33,982 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Artivion by 5.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,686,502 shares of the company’s stock worth $30,156,000 after purchasing an additional 80,214 shares during the last quarter. Wasatch Advisors LP grew its position in Artivion by 108.8% during the 1st quarter. Wasatch Advisors LP now owns 1,083,568 shares of the company’s stock worth $22,928,000 after purchasing an additional 564,549 shares during the last quarter. Finally, First Eagle Investment Management LLC grew its position in Artivion by 4.9% during the 2nd quarter. First Eagle Investment Management LLC now owns 598,148 shares of the company’s stock worth $15,342,000 after purchasing an additional 27,906 shares during the last quarter. Institutional investors own 86.37% of the company’s stock.

About Artivion

Artivion, Inc manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo.